April 19, 2013 – Executive search firm Epsen Fuller Group has placed Heidi M. Hagen as the new chief operating officer and head of global operations strategy at SOTIO. Ms. Hagen most recently served as senior vice president, operations at Dendreon. “This role is very narrowly focused on cutting-edge therapies based on activated dendritic cells that trigger the immune system for the treatment of cancer and autoimmune diseases,” said Thomas Fuller, managing partner of Epsen Fuller Group and leader on this project. “We were looking for an individual with the real drive and passion to lead the way in commercializing the science of cell manufacturing, thereby enabling SOTIO to flourish as an innovative and fast-growth organization and reinforce its commitment to connecting patients and science.” SOTIO Group is a biotechnology group developing new therapies based on activated dendritic cells, focusing on the treatment of cancer and autoimmune diseases.
Share This Article